<DOC>
	<DOCNO>NCT00185263</DOCNO>
	<brief_summary>The purpose study determine whether single intracoronary infusion Ad5FGF-4 effective improving exercise capacity measure exercise treadmill test , angina functional class , patient symptom , quality life , cardiovascular outcome . To dos study , 2.87x10 ( 8 ) 2.87x10 ( 9 ) viral particle , evaluate dose-response Ad5FGF-4 . Short-term long-term safety Ad5FGF-4 also evaluate .</brief_summary>
	<brief_title>Safety Efficacy Intracoronary Ad5FGF-4 Patients With Stable Angina</brief_title>
	<detailed_description />
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<criteria>CCS class II IV , technically unsuitable revascularization CABG PTCA able exercise 3 10 minute treadmill Unstable angina , CCS class 1 angina optimal candidate revascularization</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>angina</keyword>
	<keyword>FGF-4</keyword>
	<keyword>angiogenesis</keyword>
	<keyword>adenovector</keyword>
	<keyword>growth factor</keyword>
	<keyword>myocardial ischemia</keyword>
	<keyword>revascularization</keyword>
</DOC>